Is N -acetylcysteine effective in treating patients with coronavirus disease 2019? A meta-analysis.

ABSTRACT:

Background

Coronavirus disease 2019 (COVID-19) is a global pandemic caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2). It has brought tremendous challenges to public health and medical systems around the world. The current strategy for drug repurposing has accumulated some evidence on the use of N -acetylcysteine (NAC) in treating patients with COVID-19. However, the evidence remains debated.

Methods

We performed the systematic review and meta-analysis that complies with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Five databases and reference lists were searched from inception to May 14, 2022. Studies evaluating the efficacy of NAC in treating patients with COVID-19 were regarded as eligible. The revie

SUBMITTER: Chen CH 

PROVIDER: S-EPMC12755568 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature